Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-258694) and Form S-8 (Nos. 333-226234, 333-254883, 333-264005, 333-268328, 333-270125, and 333-275366) of Crinetics Pharmaceuticals, Inc. (the "Company") of our reports dated February 28, 2024, relating to the consolidated financial statements and the effectiveness of the Company’s internal control over financial reporting, which appear in this Annual Report on Form 10-K.

/s/ BDO USA, P.C.

San Diego, California

February 28, 2024